News Archive - Eos Advisory LLP

News

October 3, 2022

SEIS limit increased to £250k

September 6, 2022

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets

September 5, 2022

Cleantech Startup Penrhos Bio Raises £1m with Support from Eos

August 31, 2022

Eos portfolio company, RAB-Microfluidics gets £2.2 million to scale-up oil analysis device

August 23, 2022

Eos portfolio company, Cumulus Oncology is the first oncology drug development accelerator in Europe.

August 5, 2022

Eos is supporting Ready Steady Grow! 2022

All News

SEIS limit increased to £250k

October 3, 2022

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets

September 6, 2022

Cleantech Startup Penrhos Bio Raises £1m with Support from Eos

September 5, 2022

Eos portfolio company, RAB-Microfluidics gets £2.2 million to scale-up oil analysis device

August 31, 2022

Eos portfolio company, Cumulus Oncology is the first oncology drug development accelerator in Europe.

August 23, 2022

Eos is supporting Ready Steady Grow! 2022

August 5, 2022

Spin-out company aiming to replace harmful plastic microbeads receives £1.3M investment

June 28, 2022

Andrew Durkie has joined Eos as a Partner alongside Andy Lothian and Sandy Kennedy as Growth Advisors as we work to support our portfolio of high impact companie

June 13, 2022

Ana Stewart talks to FutureScot about her work on the Scottish Government-commissioned evaluation into Women in Enterprise

June 1, 2022

Eos portfolio company Rooser raises $23M for its seafood trading platform

April 25, 2022

Carcinotech secures £1.6m funding to support international growth backed in-part by Eos Advisory

April 25, 2022

Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory

February 22, 2022

Registered in Scotland.
Company Number: SO306577
Eos Advisory LLP is an Appointed Representative of Javelin Ventures Limited (FCA Ref:207918), which is authorised and regulated by the Financial Conduct Authority

News

October 3, 2022

SEIS limit increased to £250k

September 6, 2022

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets

September 5, 2022

Cleantech Startup Penrhos Bio Raises £1m with Support from Eos

August 31, 2022

Eos portfolio company, RAB-Microfluidics gets £2.2 million to scale-up oil analysis device

August 23, 2022

Eos portfolio company, Cumulus Oncology is the first oncology drug development accelerator in Europe.

August 5, 2022

Eos is supporting Ready Steady Grow! 2022

All News

October 3, 2022

Read more

September 6, 2022

Read more

September 5, 2022

Read more

August 31, 2022

Read more

August 23, 2022

Read more

August 5, 2022

Read more

June 28, 2022

Read more

June 13, 2022

Read more

June 1, 2022

Read more

April 25, 2022

Read more

April 25, 2022

Read more

February 22, 2022

Read more

Discover

Links

Contact

Copyright ©

2022

Eos Advisory LLP | All rights reserved

Latest news

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.